Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort-Reference-Cited by-同舟云学术

Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort

Published:2021-06 Issue:3 Volume:6 Page:100118
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Fornarini G.,Rebuzzi S.E.,Banna G.L.,Calabrò F.,Scandurra G.,De Giorgi U.,Masini C.,Baldessari C.,Naglieri E.,Caserta C.,Manacorda S.,Maruzzo M.,Milella M.,Buttigliero C.,Tambaro R.,Ermacora P.,Morelli F.,Nolè F.,Astolfi C.,Sternberg C.N.

Funder

Roche SpA

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Immune checkpoint inhibitors for the treatment of bladder cancer;Lopez-Beltran;Cancers.,2021

2. The changing treatment landscape for metastatic urothelial carcinoma;Flaig;J Natl Compr Canc Netw.,2018

3. Current status and future directions of the use of novel immunotherapeutic agents in bladder cancer;Lenfant;Curr Opin Urol.,2020

4. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial;Galsky;Lancet.,2020

5. IMvigor130 clinical trial in patients (pts) with metastatic urothelial carcinoma (mUC): analysis of upper tract (UT) and lower tract (LT) subgroups;Santis;J Clin Oncol.,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in US patients with rheumatoid arthritis;Frontiers in Nutrition;2024-05-30

2. The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy;Frontiers in Immunology;2024-05-10

3. Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma;Frontiers in Immunology;2024-05-10

4. Prognostic and clinical pathological significance of the systemic immune-inflammation index in urothelial carcinoma: a systematic review and meta-analysis;Frontiers in Oncology;2024-03-26

5. Tumor-associated neutrophils suppress CD8+ T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis;British Journal of Cancer;2024-01-17